06/28/2019
Ad hoc release: PAION and the European Investment Bank sign financing agreement...
PAION and the European Investment Bank sign financing agreement...
Read more
06/10/2019
Press Release: FDA accepts filing of NDA for Remimazolam in the U.S.
FDA accepts filing of NDA for Remimazolam in the U.S.
Read more
05/22/2019
Press Release: Annual general Meeting approves all agenda items and elects Dr....
Annual general Meeting approves all agenda items and elects Dr....
Read more
03/09/2017
Press Release: PAION AG: Change in Management Board
PAION AG: Change in Management Board
Read more
02/28/2017
Press Release: PAION AG announces successful completion of capital increase with...
PAION AG announces successful completion of capital increase with...
Read more
02/07/2017
Press Release: PAION AG: Capital increase; preliminary, unaudited key group...
PAION AG: Capital increase; preliminary, unaudited key Group...
Read more
12/21/2016
Press Release: PAION announces clinical development progress with remimazolam by...
PAION announces clinical development progress with remimazolam by...
Read more
10/19/2016
Press Release: Positive Remimazolam phase III colonoscopy results presented at...
Positive Remimazolam phase III colonoscopy results presented at...
Read more
09/22/2016
Press Release: Remimazolam Phase III colonoscopy data to be presented at the...
Remimazolam Phase III colonoscopy data to be presented at the...
Read more
09/06/2016
Press Release: PAION announces clinical development progress with remimazolam by...
PAION announces clinical development progress with remimazolam by...
Read more
06/29/2016
Press Release: PAION completes private placement in the amount of EUR 9.6...
PAION completes private placement in the amount of EUR 9.6...
Read more
06/19/2016
Press Release: PAION reports positive remimazolam headline data in pivotal U.S....
PAION reports positive remimazolam headline data in pivotal U.S....
Read more
04/11/2016
Press Release: PAION successfully completes patient recruitment in Phase III...
PAION successfully completes patient recruitment in Phase III...
Read more